litlas
Log inCreate account

Mitesh J. Borad

Active 2003–2026

140
Papers
21,278
Citations
62
h-index
129
i10-index

Citations

Citations per year for Mitesh J. Borad2000: 1 citations2002: 2 citations2003: 3 citations2004: 16 citations2005: 8 citations2006: 14 citations2007: 10 citations2008: 9 citations2009: 15 citations2010: 44 citations2011: 59 citations2012: 95 citations2013: 90 citations2014: 94 citations2015: 121 citations2016: 126 citations2017: 127 citations2018: 132 citations2019: 542 citations2020: 886 citations2021: 1,202 citations2022: 1,324 citations2023: 980 citations2024: 1,542 citations2025: 752 citations2026: 12 citations2001: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,363 citing papers, 24% of this breakdownChina: 1,504 citing papers, 15.3% of this breakdownItaly: 606 citing papers, 6.1% of this breakdownGermany: 549 citing papers, 5.6% of this breakdownUnited Kingdom: 519 citing papers, 5.3% of this breakdownSpain: 336 citing papers, 3.4% of this breakdownFrance: 335 citing papers, 3.4% of this breakdownJapan: 327 citing papers, 3.3% of this breakdownCanada: 253 citing papers, 2.6% of this breakdownAustralia: 210 citing papers, 2.1% of this breakdownSouth Korea: 210 citing papers, 2.1% of this breakdownNetherlands: 205 citing papers, 2.1% of this breakdown
0%24%Other 24.7%

Institutions

Fields

  • Medicine56.6%
  • Biochemistry, Genetics and Molecular Biology35.8%
  • Immunology and Microbiology3.7%
  • Materials Science1%
  • Engineering1%
  • Mathematics0.3%
  • Other1.6%

Topics

  • Cholangiocarcinoma and Gallbladder Cancer Studies7.3%
  • Pancreatic and Hepatic Oncology Research5.3%
  • Hepatocellular Carcinoma Treatment and Prognosis3.9%
  • MicroRNA in disease regulation3.8%
  • Cancer Immunotherapy and Biomarkers3.8%
  • Cancer Genomics and Diagnostics3.7%
  • Other72.2%

Coauthors

All papers

Open in search
  1. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

    Authors: Ghassan K. Abou‐Alfa, Vaibhav Sahai, Antoine Hollebecque, Gina M. Vaccaro, Davide Melisi, Raed Moh’d Taiseer Al-Rajabi, Andrew Scott Paulson, Mitesh J. Borad, David Gallinson, Adrian Murphy, Do‐Youn Oh, Efrat Dotan, Daniel V.T. Catenacci, Eric Van Cutsem, Tao Ji, Christine Lihou, Hui‐Ling Zhen, Luis Féliz, Arndt Vogel - The Lancet Oncology 2020 cited by 1,575

  2. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

    Authors: David S. Hong, Yoon‐Koo Kang, Mitesh J. Borad, Jasgit C. Sachdev, Samuel Ejadi, Ho Yeong Lim, Andrew Brenner, Keunchil Park, Jae‐Lyun Lee, Tae‐You Kim, SangJoon Shin, Carlos Becerra, Gerald S. Falchook, Jay Stoudemire, Desiree Martin, Kevin Kelnar, Heidi J. Peltier, Vinícius Bonato, Andreas G. Bader, Susan Smith, Sinil Kim, Vincent O’Neill, Muhammad Shaalan Beg - British Journal of Cancer 2020 cited by 912

  3. Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

    Authors: Ghassan K. Abou‐Alfa, Teresa Macarulla, Milind Javle, Robin Kate Kelley, Sam Joseph Lubner, Jorge Adeva, James M. Cleary, Daniel V.T. Catenacci, Mitesh J. Borad, John Bridgewater, William Proctor Harris, Adrian Murphy, Do‐Youn Oh, Jonathan Whisenant, Maeve A. Lowery, Lipika Goyal, Rachna T. Shroff, Anthony B. El-Khoueiry, Bin Fan, Bin Wu, Christina X. Chamberlain, Liewen Jiang, Camelia Gliser, Shuchi S. Pandya, Juan W. Valle, Andrew X. Zhu - The Lancet Oncology 2020 cited by 1,075

  4. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    Authors: Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott, Daniel A. Anaya, Robert A. Anders, Chandrakanth Are, Melinda Bachini, Mitesh J. Borad, Daniel B. Brown, Adam M. Burgoyne, Prabhleen Chahal, Daniel T. Chang, Jordan M. Cloyd, Anne M. Covey, Evan S. Glazer, Lipika Goyal, William G. Hawkins, Renuka Iyer, Rojymon Jacob, Robin Kate Kelley, Robin D. Kim, Matthew H. Levine, Manisha Palta, James O. Park, Steven S. Raman, Sanjay S. Reddy, Vaibhav Sahai, Tracey E. Schefter, Gagandeep Singh, Stacey Stein, Jean‐Nicolas Vauthey, Alan P. Venook, Adam C. Yopp, Nicole R. McMillian, Cindy Hochstetler, Susan Darlow - Journal of the National Comprehensive Cancer Network 2021 cited by 1,041

  5. BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

    Authors: Bruno Bockorny, Valerya Semenisty, Teresa Macarulla, Erkut Borazanci, Brian M. Wolpin, Salomon M. Stemmer, Talia Golan, Ravit Geva, Mitesh J. Borad, Katrina S. Pedersen, Joon Oh Park, Robert A. Ramirez, David Gutiérrez Abad, Jaime Feliú, Andrés Muñoz, Mariano Ponz‐Sarvisé, Amnon Peled, Tzipora M Lustig, Osnat Bohana‐Kashtan, Stephen M. Shaw, Ella Sorani, Marya Chaney, Shaul Kadosh, Abi Vainstein Haras, Daniel D. Von Hoff, Manuel Hidalgo - Nature Medicine 2020 cited by 533

  6. Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation

    Authors: Andrew X. Zhu, Teresa Macarulla, Milind Javle, Robin Kate Kelley, Sam Joseph Lubner, Jorge Adeva, James M. Cleary, Daniel V.T. Catenacci, Mitesh J. Borad, John Bridgewater, William Proctor Harris, Adrian Murphy, Do‐Youn Oh, Jonathan Whisenant, Maeve A. Lowery, Lipika Goyal, Rachna T. Shroff, Anthony B. El-Khoueiry, Christina X. Chamberlain, Elia Aguado-Fraile, Sung Choe, Bin Wu, Hua Liu, Camelia Gliser, Shuchi S. Pandya, Juan W. Valle, Ghassan K. Abou‐Alfa - JAMA Oncology 2021 cited by 473

  7. Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study

    Authors: Milind Javle, Sameek Roychowdhury, Robin Kate Kelley, Saeed Sadeghi, Teresa Macarulla, Karl Heinz Weiss, Dirk‐Thomas Waldschmidt, Lipika Goyal, Ivan Borbath, Anthony B. El-Khoueiry, Mitesh J. Borad, Wei Peng Yong, Philip A. Philip, Michael Bitzer, S. Tanasanvimon, Li Ai, Amit Pande, Harris S. Soifer, Stacie Peacock Shepherd, Susan Moran, Andrew X. Zhu, Tanios Bekaii‐Saab, Ghassan K. Abou‐Alfa - ˜The œLancet. Gastroenterology & hepatology 2021 cited by 425

  8. Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

    Authors: Muhammad S. Beg, Andrew Brenner, Jasgit C. Sachdev, Mitesh J. Borad, Yoon‐Koo Kang, Jay Stoudemire, Susan Smith, Andreas G. Bader, Sinil Kim, David S. Hong - Investigational New Drugs 2016 cited by 884

  9. Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study

    Authors: Robin Kate Kelley, Bruno Sangro, William Proctor Harris, Masafumi Ikeda, Takuji Okusaka, Yoon‐Koo Kang, Shukui Qin, David Tai, Ho Yeong Lim, Thomas Yau, Wei Peng Yong, Ann‐Lii Cheng, Antonio Gasbarrini, Silvia Damian, Jordi Bruix, Mitesh J. Borad, Johanna C. Bendell, Tae‐You Kim, Nathan Standifer, Philip He, Mallory Makowsky, Alejandra Negro, Masatoshi Kudo, Ghassan K. Abou‐Alfa - Journal of Clinical Oncology 2021 cited by 438

  10. Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study

    Authors: Milind Javle, Mitesh J. Borad, Nilofer S. Azad, Razelle Kurzrock, Ghassan K. Abou‐Alfa, Ben George, John D. Hainsworth, Funda Meric‐Bernstam, Charles Swanton, Christopher J. Sweeney, Claire F. Friedman, Ron Bose, David R. Spigel, Yong Wang, Jonathan Levy, Katja Schulze, Vaikunth Cuchelkar, Arisha Patel, Howard A. Burris - The Lancet Oncology 2021 cited by 406

  11. Hepatocytes direct the formation of a pro-metastatic niche in the liver

    Authors: Jae W. Lee, Meredith L. Stone, Paige M. Porrett, Stacy K. Thomas, Chad A. Komar, Joey H. Li, Devora Delman, Kathleen Graham, Whitney L. Gladney, Xia Hua, Taylor A. Black, Austin L. Chien, Krishna S. Majmundar, Jeffrey C. Thompson, Stephanie S. Yee, Mark H. O’Hara, Charu Aggarwal, Dong Xin, Abraham Shaked, Mingming Gao, Dexi Liu, Mitesh J. Borad, Ramesh K. Ramanathan, Erica L. Carpenter, Ailing Ji, Maria C. de Beer, Frederick C. de Beer, Nancy R. Webb, Gregory L. Beatty - Nature 2019 cited by 423

  12. Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma

    Authors: Milind Javle, Maeve A. Lowery, Rachna T. Shroff, Karl Heinz Weiss, Christoph Springfeld, Mitesh J. Borad, Ramesh K. Ramanathan, Lipika Goyal, Saeed Sadeghi, Teresa Macarulla, Anthony B. El-Khoueiry, Robin Kate Kelley, Ivan Borbath, Su Pin Choo, Do‐Youn Oh, Philip A. Philip, Li‐Tzong Chen, Thanyanan Reungwetwattana, Eric Van Cutsem, Kun‐Huei Yeh, Kristen K. Ciombor, Richard S. Finn, Anuradha Patel, Suman Sen, Dale Porter, Randi Isaacs, Andrew X. Zhu, Ghassan K. Abou‐Alfa, Tanios Bekaii‐Saab - Journal of Clinical Oncology 2017 cited by 715

  13. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles

    Authors: Farshad Farshidfar, Siyuan Zheng, Marie‐Claude Gingras, Yulia Newton, Juliann Shih, A. Gordon Robertson, Toshinori Hinoue, Katherine A. Hoadley, Ewan A. Gibb, Jason Roszik, Kyle R. Covington, Chia-Chin Wu, Eve Shinbrot, Nicolas Stransky, Apurva M. Hegde, Ju Dong Yang, Ed Reznik, Sara Sadeghi, Chandra Sekhar Pedamallu, Akinyemi I. Ojesina, Julian M. Hess, J. Todd Auman, Suhn K. Rhie, Reanne Bowlby, Mitesh J. Borad, Rehan Akbani, Loretta K. Allotey, Adrian Ally, Domenico Alvaro, Jesper B. Andersen, Elizabeth L. Appelbaum, Arshi Arora, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Nabeel Bardeesy, Oliver F. Bathe, Stephen B. Baylin, Rameen Beroukhim, Mario Berríos, Tom Bodenheimer, Lori Boice, Moiz S. Bootwalla, Mitesh J. Borad, Jay Bowen, Reanne Bowlby, Maria Consiglia Bragazzi, Denise Brooks, Vincenzo Cardinale, Rebecca Carlsen, Guido Carpino, André Lopes Carvalho, Roongruedee Chaiteerakij, Vishal C. Chandan, Andrew D. Cherniack, Lynda Chin, Juok Cho, Gina Choe, Eric Chuah, Sudha Chudamani, Carrie Cibulskis, Matthew G. Cordes, Kyle R. Covington, Daniel Crain, Erin Curley, Agostino Maria De Rose, Timothy Defreitas, John A. Demchok, Vikram Deshpande, Noreen Dhalla, Li Ding, Kimberley Evason, Farshad Farshidfar, Ina Felau, Martin L. Ferguson, Wai Chin Foo, Antonio Franchitto, Scott Frazer, Catrina C. Fronick, Lucinda A. Fulton, Robert S. Fulton, Stacey Gabriel, Johanna Gardner, Julie M. Gastier‐Foster, Eugenio Gaudio, Nils Gehlenborg, Giannicola Genovese, Mark Gerken, Gad Getz, Nasra H. Giama, Richard A. Gibbs, Marie-Claude Gingras, Felice Giuliante, Gian Luca Grazi, D. Neil Hayes, Apurva M. Hegde, David I. Heiman, Julian M. Hess, Toshinori Hinoue, Katherine A. Hoadley and 136 more - Cell Reports 2017 cited by 612

  14. NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023

    Authors: Al B. Benson, Michael I. D’Angelica, Thomas A. Abrams, Daniel E. Abbott, Aijaz Ahmed, Daniel A. Anaya, Robert A. Anders, Chandrakanth Are, Melinda Bachini, David C. Binder, Mitesh J. Borad, Christopher L. Bowlus, Daniel B. Brown, Adam M. Burgoyne, Jason Castellanos, Prabhleen Chahal, Jordan M. Cloyd, Anne M. Covey, Evan S. Glazer, William G. Hawkins, Renuka Iyer, Rojymon Jacob, Lawrence J. Jennings, Robin Kate Kelley, Robin D. Kim, Matthew H. Levine, Manisha Palta, James O. Park, Steven S. Raman, Sanjay S. Reddy, Sean M. Ronnekleiv‐Kelly, Vaibhav Sahai, Gagandeep Singh, Stacey Stein, Anita Turk, Jean‐Nicolas Vauthey, Alan P. Venook, Adam C. Yopp, Nicole R. McMillian, Ryan Schonfeld, Cindy Hochstetler - Journal of the National Comprehensive Cancer Network 2023 cited by 206

  15. Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers

    Authors: Rachna T. Shroff, Milind Javle, Lianchun Xiao, Ahmed O. Kaseb, Gauri R. Varadhachary, Robert A. Wolff, Kanwal Raghav, Michiko Iwasaki, Peter Masci, Ramesh K. Ramanathan, Daniel H. Ahn, Tanios Bekaii‐Saab, Mitesh J. Borad - JAMA Oncology 2019 cited by 473

  16. The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer

    Authors: J.E. Berchuck, Francesco Facchinetti, Daniel DiToro, Islam Baiev, Umair Majeed, Sylvia A. Reyes, Christopher S. Chen, Karen Zhang, R. Sharman, Pedro Luiz Serrano Usón, Jochen Maurer, Rachna T. Shroff, Colin C. Pritchard, Meng‐Ju Wu, Daniel V.T. Catenacci, M. M. Javle, Luc Friboulet, Antoine Hollebecque, Nabeel Bardeesy, Andrew X. Zhu, Jochen K. Lennerz, Benjamin Kye Jyn Tan, Mitesh J. Borad, Aparna R. Parikh, Lesli A. Kiedrowski, Robin Kate Kelley, Kabir Mody, Dejan Juric, Love Goyal - Annals of Oncology 2022 cited by 139

  17. FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice

    Authors: Anuhya Kommalapati, Sri Harsha Tella, Mitesh J. Borad, Milind Javle, Amit Mahipal - Cancers 2021 cited by 152

  18. Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers

    Authors: James J. Harding, Sarina A. Piha‐Paul, Ronak Shah, Jessica Murphy, James M. Cleary, Geoffrey I. Shapiro, David I. Quinn, Irene Braña, Víctor Moreno, Mitesh J. Borad, Sherene Loi, Iben Spanggaard, Haeseong Park, James M. Ford, Mónica Arnedos, Salomon M. Stemmer, Christelle de la Fouchardière, Christos Fountzilas, Jie Zhang, Daniel DiPrimeo, Casey Savin, S. Duygu Selçuklu, Michael F. Berger, Lisa D. Eli, Funda Meric‐Bernstam, Komal Jhaveri, David B. Solit, Ghassan K. Abou‐Alfa - Nature Communications 2023 cited by 85

  19. FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements

    Authors: Tanios S Bekaii-Saab, Juan W. Valle, Eric Van Cutsem, Lorenza Rimassa, Junji Furuse, Tatsuya Ioka, Davide Melisi, Teresa Macarulla, John Bridgewater, Harpreet Wasan, Mitesh J. Borad, Ghassan K. Abou‐Alfa, Ping Jiang, Christine Lihou, Hui‐Ling Zhen, Ekaterine Asatiani, Luis Féliz, Arndt Vogel - Future Oncology 2020 cited by 165

  20. SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.

    Authors: Rachna T. Shroff, Katherine A. Guthrie, Aaron J. Scott, Mitesh J. Borad, Laura W. Goff, Khalid Matin, Amit Mahipal, Aparna Kalyan, Milind Javle, Carol Aghajanian, Benjamin Tan, P. Cheema, Anuj Patel, Renuka Iyer, Robin Kate Kelley, Jaykumar Thumar, Anthony B. El-Khoueiry, E. Gabriela Chiorean, Howard S. Höchster, Philip Agop Philip - Journal of Clinical Oncology 2023 cited by 99

  21. Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial

    Authors: Daniel D. Von Hoff, Ramesh K. Ramanathan, Mitesh J. Borad, Daniel A. Laheru, Lon Smith, Tina E. Wood, Ronald L. Korn, Neil Desai, Vuong Trieu, J. L. Mesías Iglesias, Hui Zhang, Patrick Soon‐Shiong, Tao Shi, N.V. Rajeshkumar, Anirban Maitra, Manuel Hidalgo - Journal of Clinical Oncology 2011 cited by 1,045

  22. Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

    Authors: Daniel D. Von Hoff, Joseph J. Stephenson, Peter J. Rosen, David Loesch, Mitesh J. Borad, Stephen P. Anthony, Gayle Jameson, Susan B. Brown, Nina Cantafio, Donald Richards, Tom R. Fitch, Ernesto Wasserman, Cristian Fernández, Sylvan Green, William Sutherland, Michael Bittner, Arlet Alarcon, David Mallery, Robert Penny - Journal of Clinical Oncology 2010 cited by 643

  23. Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma

    Authors: Mohamad Bassam Sonbol, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Daniel Almquist, Syeda A. Mina, Jehad Almasri, Shiv Shah, Diana Almader‐Douglas, Pedro Luiz Serrano Usón, Amit Mahipal, Wen Wee, Zhaohui Jin, Kabir Mody, Jason S. Starr, Mitesh J. Borad, Daniel H. Ahn, M. Hassan Murad, Tanios Bekaii‐Saab - JAMA Oncology 2020 cited by 199

  24. Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma

    Authors: Rondell P. Graham, Emily G. Barr Fritcher, Ekaterina Pestova, John Schulz, Leonid A. Sitailo, George Vasmatzis, Stephen J. Murphy, Robert R. McWilliams, Steven N. Hart, Kevin C. Halling, Lewis R. Roberts, Gregory J. Gores, Fergus J. Couch, Lizhi Zhang, Mitesh J. Borad, Benjamin R. Kipp - Human Pathology 2014 cited by 320